dimaprit has been researched along with Acute Myelogenous Leukemia in 2 studies
Dimaprit: A histamine H2 receptor agonist that is often used to study the activity of histamine and its receptors.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sawutz, DG | 2 |
| Kalinyak, K | 1 |
| Whitsett, JA | 2 |
| Johnson, CL | 2 |
| Kalinyak, KA | 1 |
| Lampkin, BC | 1 |
2 other studies available for dimaprit and Acute Myelogenous Leukemia
| Article | Year |
|---|---|
Histamine H2 receptor desensitization in HL-60 human promyelocytic leukemia cells.
Topics: 1-Methyl-3-isobutylxanthine; Cell Differentiation; Cell Line; Cimetidine; Cyclic AMP; Dimaprit; Dino | 1984 |
Effects of dimaprit on growth and differentiation of human promyelocytic cell line, HL-60.
Topics: Bone Marrow; Bone Marrow Cells; Bucladesine; Cell Differentiation; Cell Division; Cell Line; Cyclic | 1985 |